High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin
concentrations and resolve minor changes in biomarker concentrations. Clinically, this …

Heart failure (HF) is a major comorbidity in patients with end-stage kidney disease (ESKD).
The pathogenesis of HF in patients on renal replacement therapy represents the confluence …

Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …

Background Cardiac troponin T is independently associated with cardiovascular events and
mortality in patients with chronic kidney disease (CKD). Serum levels of high sensitivity …

High-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-
proBNP) strongly predict heart failure (HF) in the general population. However, the …

Background Cardiac biomarkers may signal mechanistic pathways involved in heart failure
(HF), a leading complication in chronic kidney disease. We tested the associations of NT …

Background Cardiovascular disease is a major cause of death in patients with stage 4–5
Chronic Kidney disease (CKD, eGFR< 30). There are only limited data on the risk factors …

Cardiac biomarkers, such as cardiac troponin T (cTnT), brain natriuretic peptide (BNP), and
N-terminal-pro-BNP (NT-pro-BNP), are commonly used to diagnose acute coronary …

It is well known that the population with chronic kidney disease (CKD) is at greater risk for
cardiovascular disease and death than the general population. The use and interpretation of …

Rationale & Objective Circulating cardiac biomarkers may signal potential mechanistic
pathways involved in heart failure (HF) and atrial fibrillation (AF). Single measures of …